TEM:NASDAQ
Tempus AI Inc
$59.01
arrow_upward
+0.46%(+0.27) 1D
$58.92
arrow_downward
-0.15% (-0.090)bedtimeAfter hours
Closed: Sep 11, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TEM...
Open
$59.47
High
$60.38
Low
$58.48
Mkt. cap
10.65B
Avg. vol.
6.97M
Volume
3.69M
52-wk high
$104.32
52-wk low
$40.77
EPS
-$1.43
Shares outstanding
175.39M
No. of employees
4K
Open
$59.47
High
$60.38
Low
$58.48
Mkt. cap
10.65B
Avg. vol.
6.97M
Volume
3.69M
52-wk high
$104.32
52-wk low
$40.77
EPS
-$1.43
Shares outstanding
175.39M
No. of employees
4K
News stories
From web sources and news partners
Investing.com
·
12 hours ago
Tempus AI plans 100,000 whole genome sequencing dataset
Benzinga
·
12 hours ago
Nvidia, Snowflake, Chubb And A Health Care Stock On CNBC’s ‘Final Trades’
MarketBeat
·
12 hours ago
Tempus AI (NASDAQ:TEM) Stock Price Expected to Rise, HC Wainwright Analyst Says
GuruFocus
·
12 hours ago
TEM Maintained by HC Wainwright & Co. -- Price Target Raised to $66.00
Profile
Tempus AI, Inc. is an American health technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. It was established by Lefkofsky soon after his wife was diagnosed with breast cancer. Tempus uses data and artificial intelligence to create precision medicine services, including diagnostics, for oncology, cardiology, radiology, and depression. The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM." Wikipedia
About Tempus AI Inc
CEOEric Lefkofsky
Employees3.8K
Founded2015
HeadquartersChicago, Illinois, United States
SectorHealth care
Websitetempus.com